Global Business Travel Group's CWT Bid Won't Hurt Competition, U.K. Regulator Says

Dow Jones
02-19
 

By Edith Hancock

 

The U.K.'s Competition and Markets Authority should clear Global Business Travel Group's $570 million acquisition of CWT Holdings, the regulator's experts have said after initially raising concerns the deal could raise prices for business travel customers.

Following a further review into the merger the U.K. regulator said Tuesday that CWT is a significantly weaker competitor than in the past and is likely to continue to weaken in the future.

"In this case, having considered all of the evidence in the round, particularly the further analysis of CWT's financial position, we have now provisionally concluded that the merger will not result in a substantial lessening of competition in corporate travel management services," Martin Coleman, chair of the panel of experts conducting this investigation, said.

The regulator decided to launch an in-depth investigation into the deal last year, saying the merged company is likely to substantially weaken competition in the business travel sector.

The CMA said Tuesday that it wants to hear feedback from its latest report, setting a Feb. 25 deadline for comments. The watchdog is expected to make its final decision on the deal by March 9.

GBT and CWT's deal was announced in March 2024, prompting the CMA to open its merger probe on July 30. It is also being scrutinized in the U.S., where the Department of Justice filed a lawsuit to block it on Jan. 10.

"The updated provisional conclusions by the CMA is an important milestone toward the consummation of the transaction," Eric Bock, GBT's chief legal officer, said in a statement Tuesday. The CMA's new findings reinforce the company's belief that the U.S. lawsuit is "fundamentally flawed" and disregards numerous competitors in the space, he said.

 

Write to Edith Hancock at edith.hancock@wsj.com

 

(END) Dow Jones Newswires

February 18, 2025 12:04 ET (17:04 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10